STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNSP
  4. [8-K] CNS Pharmaceuticals, Inc. Reports Material Event

[8-K] CNS Pharmaceuticals, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock CNSP logo
CNS Pharmaceuticals

NASDAQ:CNSP

CNSP Rankings

#10260 Ranked by Market Cap
N/A Ranked by Dividends

CNSP Latest News

Jul 22, 2025
CNS Pharmaceuticals to Participate in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
Jul 18, 2025
CNS Pharmaceuticals Announces Reverse Stock Split
Jul 9, 2025
CNS Pharmaceuticals Participates in Virtual Investor CEO Connect Segment
Jun 24, 2025
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment Discussing Glioblastoma Multiforme (GBM) and Lead Product Candidate TPI 287
Jun 5, 2025
CNS Pharmaceuticals' Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit

CNSP Latest SEC Filings

Jul 15, 2025
[8-K] CNS Pharmaceuticals, Inc. Reports Material Event

CNSP Stock Data

4.73M
454.19k
0.44%
2.58%
17.91%
Biotechnology
Pharmaceutical Preparations
Link
United States
HOUSTON